17.05.08 - Assessment of response to treatment

Links to the 4 presentations given during this scientific event (members only)     Usefulness and limits of the SUV for tumor characterization and patient monitoring in FDG PET/CT (I. Buvat, Imagerie et Modélisation en Neurobiologie et Cancérologie, Université de Paris)  Restaging in bronchial carcinoma (P. Van Schil, Thorax en Vaatheelkunde, UZ Antwerpen) The role of PET-CT in response evaluation of malignant lymphoma (L. Brepoels, Nucleaire Geneeskunde, UZ Leuven) PET-CT for monitoring metastatic breast cancer (C. Garcia, Médecine Nucléaire, Institut Bordet, Bruxelles)